Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 5/20 | 0.41 |
| ▸ | CA12 | O43570 | 5/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | CDC25B | P30305 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Saccharin SCHEMBL1322905 | 0.98 | GPR3 (0.43) | GPR3CA9CA12KMT2ACA2 | |
| Saccharin SCHEMBL953945 | 0.96 | GPR3 (0.44) | GPR3CA9CA12KMT2ACA2 | |
| Saccharin SCHEMBL3372 | 0.96 | GPR3 (0.44) | GPR3CA9CA12KMT2ACA2 | |
| Saccharin SCHEMBL49027 | 0.96 | GPR3 (0.44) | GPR3CA9CA12KMT2ACA2 | |
| Saccharin SCHEMBL8668442 | 0.96 | GPR3 (0.44) | GPR3CA9CA12KMT2ACA2 | |
| Saccharin SCHEMBL10399957 | 0.96 | GPR3 (0.44) | GPR3CA9CA12KMT2ACA2 | |
| Saccharin SCHEMBL5870938 | 0.96 | GPR3 (0.44) | GPR3CA9CA12KMT2ACA2 | |
| Saccharin SCHEMBL2954783 | 0.96 | GPR3 (0.44) | GPR3CA9CA12KMT2ACA2 | |
| Saccharin SCHEMBL787894 | 0.96 | GPR3 (0.44) | GPR3CA9CA12KMT2ACA2 | |
| Saccharin SCHEMBL10618576 | 0.96 | GPR3 (0.44) | GPR3CA9CA12KMT2ACA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3860342-A1 | COMPOSITIONS AND METHODS FOR ISOLATING CIRCULATING CELLS | Prescient Pharma LLC (US) | 2021-08-11 | — | — | EP | claimed |
| US-20200109394-A1 | COMPOSITIONS AND METHODS FOR ISOLATING CIRCULATING CELLS | REED, KENNETH M. | 2020-04-09 | — | — | US | claimed |
| WO-2020072840-A1 | COMPOSITIONS AND METHODS FOR ISOLATING CIRCULATING CELLS | PRESCIENT PHARMA LLC (US) | 2020-04-09 | — | — | WO | claimed |
| EP-3603632-A1 | TREATMENT OR PREVENTION OF ANAEMIA IN OFFSPRING OF NON-HUMAN MAMMALS | Pharmacosmos Holding A/s (DK) | 2020-02-05 | — | — | EP | claimed |
| EP-3212182-B1 | TREATMENT OR PREVENTION OF ANAEMIA IN PREGNANT NON-HUMAN MAMMALS AND OFFSPRING | PHARMACOSMOS HOLDING AS (DK) | 2019-06-26 | — | — | EP | claimed |
| US-20170333470-A1 | TREATMENT OR PREVENTION OF ANAEMIA IN PREGNANT NON-HUMAN MAMMALS | PHARMACOSMOS HOLDING A/S (DK) | 2017-11-23 | — | — | US | claimed |
| CN-107206017-A | Treatment or prevention of anemia in pregnant non-human mammals | 法码科思莫斯控股有限公司 | 2017-09-26 | — | — | CN | claimed |
| EP-3212182-A1 | TREATMENT OR PREVENTION OF ANAEMIA IN PREGNANT NON-HUMAN MAMMALS | Pharmacosmos Holding A/s (DK) | 2017-09-06 | — | — | EP | claimed |
| WO-2016066172-A1 | TREATMENT OR PREVENTION OF ANAEMIA IN PREGNANT NON-HUMAN MAMMALS | PHARMACOSMOS HOLDING A/S (DK) | 2016-05-06 | — | — | WO | claimed |
| US-8053470-B2 | precisely control the molecular weight of the polynuclear ferric hydroxide-saccharide complex without an effect on the other characteristics of the product, for example its saccharide content or isoelectric point etc, | CHONGQING PHARMACEUTICAL RESEARCH INSTITUTE CO., LTD. (CN) | 2011-11-08 | — | — | US | claimed |
| US-20100176340-A1 | BUFFERED COMPOSITIONS FOR DIALYSIS | ADVANCED RENAL TECHNOLOGIES (US) | 2010-07-15 | — | — | US | claimed |
| EP-1641473-B1 | BUFFERED COMPOSITIONS FOR DIALYSIS | ADVANCED RENAL TECHNOLOGIES (US) | 2010-04-14 | — | — | EP | claimed |
| WO-1998046090-A1 | ANTI-OXYDANT MULTIVITAMIN PREPARATION | HOPITAL SAINTE-JUSTINE (CA) | 1998-10-22 | — | — | WO | claimed |
| US-20240238335-A1 | FERRITIN COMPOSITION TOLERABILITY | SIDERO BIOSCIENCE, LLC | 2024-07-18 | — | — | US | disclosed |
| US-12030962-B2 | Stable iron oligosaccharide compound | PHARMACOSMOS HOLDING A/S (DK) | 2024-07-09 | — | — | US | disclosed |
| EP-4340642-A1 | FERRITIN COMPOSITION TOLERABILITY | Sidero Bioscience, LLC (US) | 2024-03-27 | — | — | EP | disclosed |
| US-20040060865-A1 | Citrate concentrates comprising acetate and/or lactate | ADVANCED RENAL TECHNOLOGIES | 2004-04-01 | — | — | US | disclosed |
| CN-1473265-A | Method for producing purified hematinic iron-sugar complex and product production | 色品先进技术股份有限公司 | 2004-02-04 | — | — | CN | disclosed |
| WO-1998046090-A1 | ANTI-OXYDANT MULTIVITAMIN PREPARATION | HOPITAL SAINTE-JUSTINE (CA) | 1998-10-22 | — | — | WO | disclosed |
| US-4923575-A | Aqueous alkaline bath and process for electrodeposition of a zinc-iron alloy | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-05-08 | — | — | US | disclosed |